ASX 300 Healthcare Stock Sigma Halts Trading Amid Chemist Warehouse Deal Rumors

2 min read | December 06, 2023 11:04 PM AEDT | By Team Kalkine Media

Google News:

ASX 300 Healthcare Stock Sigma Halts Trading Amid Chemist Warehouse Deal Rumors — Image source: Guschenkova, Shutterstock

Recent News

Santos (ASX:STO) After the Takeover Collapse: Bargain or Value Trap?

Why Pro Medicus (ASX:PME) Is Leading the Growth Stock Conversation

Is 360 (ASX:360) Amid ASX 200 Revealing Growth’s New Reality?

Why 360 (ASX:360) ASX 200 Is Facing a New Growth Test

Make Kalkine Media
My Trusted Source

Sigma Healthcare Ltd (ASX:SIG), a healthcare stock listed on the ASX 300, witnessed a surge in its share price on Wednesday before being placed into a trading halt at the company's request. This development aligns with the broader dynamics of ASX healthcare stocks. The trading halt was initiated pending the release of a significant announcement related to a potential material transaction.

In their official request for the trading halt, Sigma Healthcare stated, "The trading halt is requested pending an announcement relating to a potential material transaction and is required to ensure Sigma shares are not trading on a misinformed basis." Investors in ASX healthcare stocks will likely closely monitor developments related to Sigma Healthcare's anticipated announcement and its potential impact on the ASX:SIG's share price.

Potential Deal with Chemist Warehouse:

There are strong speculations in the market that Sigma Healthcare is gearing up to announce a reverse listing deal involving pharmacy giant Chemist Warehouse. Reports suggest that the two companies are close to finalizing a deal where Chemist Warehouse would take board control and a majority ownership stake in Sigma.

Unnamed sources have mentioned that the deal might involve Sigma seeking to raise either $350 million or $400 million from investors. This capital injection would serve to strengthen Sigma's balance sheet and enhance liquidity.

While both companies have yet to confirm these reports, Sigma Healthcare has announced its intention to release details of the "material transaction" before the market opens on Friday.

Impact on Wesfarmers:

Despite the speculation and potential implications for the pharmacy industry, Wesfarmers Ltd (ASX:WES) shares have continued to rise. Wesfarmers, a conglomerate that acquired Priceline-owner Australian Pharmaceutical Industries last year for nearly $800 million, appears unaffected by the current news.

Investors and industry participants will be closely watching for the official announcement from Sigma Healthcare to gain clarity on the details and potential impact of the speculated deal with Chemist Warehouse.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.